Best Device Closure of ASD (Amplatzer Septal Occluder) Treatment Hospitals Worldwide

Max Hospital, Gurgaon offers advanced Device Closure of ASD (Amplatzer Septal Occluder) using modern interventional cardiology techniques and individualized congenital heart disease care plans. Established in 2007, the ISO, NABH, NABL accredited hospital is located in Gurgaon, India and has 104 beds, providing comprehensive cardiac care for local and international patients.

Device Closure of ASD (Amplatzer Septal Occluder) is a minimally invasive procedure used to close a suitable atrial septal defect (ASD), an opening between the upper chambers of the heart. During the procedure, an Amplatzer Septal Occluder is delivered through a catheter and positioned across the defect. Once deployed, the device spans both sides of the opening and helps prevent abnormal blood flow between the atria. The procedure is generally considered for appropriately selected secundum ASDs with suitable anatomy.

At Sikarin Hospital, Device Closure of ASD (Amplatzer Septal Occluder) is performed using specialized catheter-based cardiac techniques and comprehensive pre-procedure assessment. Established in 1979, this JCI accredited hospital in Bangkok, Thailand has 354 beds and offers advanced interventional and congenital cardiology services.

Device Closure of ASD (Amplatzer Septal Occluder) may be considered for patients with a suitable atrial septal defect where closure is clinically indicated. A catheter is introduced through a blood vessel, usually in the groin, and guided toward the heart. The Amplatzer device is then advanced through the catheter and carefully positioned across the ASD under imaging guidance. Echocardiography and cardiac imaging are used to assess the size, location, and surrounding structures of the defect before and during the procedure.

Indraprastha Apollo Hospital provides specialised Device Closure of ASD (Amplatzer Septal Occluder) with a focus on precise defect assessment, advanced transcatheter closure techniques, and individualized congenital cardiac care. Established in 1996, the JCI accredited hospital is located in Delhi, India and operates 710 beds, with modern interventional cardiology, cardiac imaging, and critical-care infrastructure.

Device Closure of ASD (Amplatzer Septal Occluder) can provide a minimally invasive alternative to open-heart surgery for selected patients with suitable secundum ASDs. Treatment planning considers the defect's size and location, surrounding tissue margins, pulmonary pressures, associated cardiac abnormalities, and the patient's overall health. Detailed echocardiographic assessment, including transesophageal or intracardiac imaging when required, helps the cardiac team select the appropriate device size and determine whether transcatheter closure is a suitable treatment option.

Venkateshwar Hospital is a trusted healthcare provider for Device Closure of ASD (Amplatzer Septal Occluder), offering minimally invasive ASD closure supported by experienced interventional cardiologists, congenital heart specialists, advanced catheterization laboratories, and multidisciplinary cardiac care. Established in 2016, the NABL, NABH- accredited hospital is situated in Delhi, India and has 325 beds.

Device Closure of ASD (Amplatzer Septal Occluder) works by placing a self-expanding occlusion device across the atrial septal defect to block the abnormal communication between the atria. The device consists of two discs connected by a central waist that conforms to the defect. Over time, heart tissue grows over the device, helping to establish permanent closure. A detailed cardiac assessment helps determine whether the defect is anatomically suitable for device closure rather than surgical repair.

At VM Medical Park Ankara, Device Closure of ASD (Amplatzer Septal Occluder) is performed using specialized catheter-based cardiac techniques and comprehensive pre-procedure assessment. Established in 2014, this JCI accredited hospital in Ankara, Turkey has 327 beds and offers advanced interventional and congenital cardiology services.

Device Closure of ASD (Amplatzer Septal Occluder) may be considered for patients with a suitable atrial septal defect where closure is clinically indicated. A catheter is introduced through a blood vessel, usually in the groin, and guided toward the heart. The Amplatzer device is then advanced through the catheter and carefully positioned across the ASD under imaging guidance. Echocardiography and cardiac imaging are used to assess the size, location, and surrounding structures of the defect before and during the procedure.

Medical Park Tokat Hospital provides specialised Device Closure of ASD (Amplatzer Septal Occluder) with a focus on precise defect assessment, advanced transcatheter closure techniques, and individualized congenital cardiac care. Established in 2015, the JCI accredited hospital is located in Tokat, Turkey and operates 157 beds, with modern interventional cardiology, cardiac imaging, and critical-care infrastructure.

Device Closure of ASD (Amplatzer Septal Occluder) can provide a minimally invasive alternative to open-heart surgery for selected patients with suitable secundum ASDs. Treatment planning considers the defect's size and location, surrounding tissue margins, pulmonary pressures, associated cardiac abnormalities, and the patient's overall health. Detailed echocardiographic assessment, including transesophageal or intracardiac imaging when required, helps the cardiac team select the appropriate device size and determine whether transcatheter closure is a suitable treatment option.

Medical Park Trabzon Star Hospital provides specialised Device Closure of ASD (Amplatzer Septal Occluder) with a focus on precise defect assessment, advanced transcatheter closure techniques, and individualized congenital cardiac care. Established in 2011, the JCI accredited hospital is located in Trabzon, Turkey and operates 120 beds, with modern interventional cardiology, cardiac imaging, and critical-care infrastructure.

Device Closure of ASD (Amplatzer Septal Occluder) can provide a minimally invasive alternative to open-heart surgery for selected patients with suitable secundum ASDs. Treatment planning considers the defect's size and location, surrounding tissue margins, pulmonary pressures, associated cardiac abnormalities, and the patient's overall health. Detailed echocardiographic assessment, including transesophageal or intracardiac imaging when required, helps the cardiac team select the appropriate device size and determine whether transcatheter closure is a suitable treatment option.

Choosing VM Medical Park Samsun Hospital for Device Closure of ASD (Amplatzer Septal Occluder) gives patients access to experienced interventional cardiologists, advanced echocardiography and imaging systems, modern catheterization facilities, and structured post-procedure cardiac care. Established in 2017, the JCI accredited hospital in Samsun, Turkey has 300 beds and provides specialized congenital heart disease services.

Device Closure of ASD (Amplatzer Septal Occluder) is typically performed under sedation or general anaesthesia depending on the patient's age and clinical requirements. The catheter carrying the occluder is guided through the vascular system into the heart, where the device is deployed across the ASD after confirming its position and stability. Patients are monitored after the procedure for heart rhythm changes, bleeding at the catheter site, device-related complications, or residual blood flow through the defect. Follow-up echocardiography is used to assess device position and closure.

At Medical Park Usak Hospital, Device Closure of ASD (Amplatzer Septal Occluder) is performed using specialized catheter-based cardiac techniques and comprehensive pre-procedure assessment. Established in 2013, this JCI accredited hospital in Usak, Turkey has 106 beds and offers advanced interventional and congenital cardiology services.

Device Closure of ASD (Amplatzer Septal Occluder) may be considered for patients with a suitable atrial septal defect where closure is clinically indicated. A catheter is introduced through a blood vessel, usually in the groin, and guided toward the heart. The Amplatzer device is then advanced through the catheter and carefully positioned across the ASD under imaging guidance. Echocardiography and cardiac imaging are used to assess the size, location, and surrounding structures of the defect before and during the procedure.

Choosing Apollo Hospitals for Device Closure of ASD (Amplatzer Septal Occluder) gives patients access to experienced interventional cardiologists, advanced echocardiography and imaging systems, modern catheterization facilities, and structured post-procedure cardiac care. Established in 1988, the JCI accredited hospital in Hyderabad, India has 550 beds and provides specialized congenital heart disease services.

Device Closure of ASD (Amplatzer Septal Occluder) is typically performed under sedation or general anaesthesia depending on the patient's age and clinical requirements. The catheter carrying the occluder is guided through the vascular system into the heart, where the device is deployed across the ASD after confirming its position and stability. Patients are monitored after the procedure for heart rhythm changes, bleeding at the catheter site, device-related complications, or residual blood flow through the defect. Follow-up echocardiography is used to assess device position and closure.

At Sterling Wockhardt Hospital, Device Closure of ASD (Amplatzer Septal Occluder) is performed using specialized catheter-based cardiac techniques and comprehensive pre-procedure assessment. Established in 2001, this NABL accredited hospital in Mumbai, India has 225 beds and offers advanced interventional and congenital cardiology services.

Device Closure of ASD (Amplatzer Septal Occluder) may be considered for patients with a suitable atrial septal defect where closure is clinically indicated. A catheter is introduced through a blood vessel, usually in the groin, and guided toward the heart. The Amplatzer device is then advanced through the catheter and carefully positioned across the ASD under imaging guidance. Echocardiography and cardiac imaging are used to assess the size, location, and surrounding structures of the defect before and during the procedure.

Star Hospitals is a trusted healthcare provider for Device Closure of ASD (Amplatzer Septal Occluder), offering minimally invasive ASD closure supported by experienced interventional cardiologists, congenital heart specialists, advanced catheterization laboratories, and multidisciplinary cardiac care. Established in 2008, the NABH, NABL- accredited hospital is situated in Hyderabad, India and has 435 beds.

Device Closure of ASD (Amplatzer Septal Occluder) works by placing a self-expanding occlusion device across the atrial septal defect to block the abnormal communication between the atria. The device consists of two discs connected by a central waist that conforms to the defect. Over time, heart tissue grows over the device, helping to establish permanent closure. A detailed cardiac assessment helps determine whether the defect is anatomically suitable for device closure rather than surgical repair.

Hospital Quironsalud Barcelona offers advanced Device Closure of ASD (Amplatzer Septal Occluder) using modern interventional cardiology techniques and individualized congenital heart disease care plans. Established in 1944, the JCI, ISO accredited hospital is located in Barcelona, Spain and has 165 beds, providing comprehensive cardiac care for local and international patients.

Device Closure of ASD (Amplatzer Septal Occluder) is a minimally invasive procedure used to close a suitable atrial septal defect (ASD), an opening between the upper chambers of the heart. During the procedure, an Amplatzer Septal Occluder is delivered through a catheter and positioned across the defect. Once deployed, the device spans both sides of the opening and helps prevent abnormal blood flow between the atria. The procedure is generally considered for appropriately selected secundum ASDs with suitable anatomy.

Avcilar Anadolu Hospital offers advanced Device Closure of ASD (Amplatzer Septal Occluder) using modern interventional cardiology techniques and individualized congenital heart disease care plans. Established in 1998, the JCI accredited hospital is located in Istanbul, Turkey and has 120 beds, providing comprehensive cardiac care for local and international patients.

Device Closure of ASD (Amplatzer Septal Occluder) is a minimally invasive procedure used to close a suitable atrial septal defect (ASD), an opening between the upper chambers of the heart. During the procedure, an Amplatzer Septal Occluder is delivered through a catheter and positioned across the defect. Once deployed, the device spans both sides of the opening and helps prevent abnormal blood flow between the atria. The procedure is generally considered for appropriately selected secundum ASDs with suitable anatomy.

Choosing Centro Medico Teknon for Device Closure of ASD (Amplatzer Septal Occluder) gives patients access to experienced interventional cardiologists, advanced echocardiography and imaging systems, modern catheterization facilities, and structured post-procedure cardiac care. Established in 1994, the JCI accredited hospital in Barcelona, Spain has 211 beds and provides specialized congenital heart disease services.

Device Closure of ASD (Amplatzer Septal Occluder) is typically performed under sedation or general anaesthesia depending on the patient's age and clinical requirements. The catheter carrying the occluder is guided through the vascular system into the heart, where the device is deployed across the ASD after confirming its position and stability. Patients are monitored after the procedure for heart rhythm changes, bleeding at the catheter site, device-related complications, or residual blood flow through the defect. Follow-up echocardiography is used to assess device position and closure.